The number of clinically diagnosed relapse pulmonary tuberculosis cases in Canada is forecasted to remain stable at 12 cases annually from 2024 to 2026, followed by a slight increase to 13 cases in 2027 and 2028. There was no percentage variation calculated over the last two years due to the data's consistent nature. However, the average compound annual growth rate (CAGR) over the five-year forecast period from 2024 to 2028 stands at approximately 1.6%.

Future trends to watch for include:

Potential breakthroughs in tuberculosis treatment and healthcare advancements that might affect the incidence rate.
Public health policies and their effectiveness in managing and preventing tuberculosis relapses in Canada.
Impact of socio-economic factors and healthcare resource allocation on the disease's trajectory.